Skip to main navigation
  • News & Investors

    News & Investors

    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact
  • Contact Us
Celsion
  • TECHNOLOGY
    • LTSL
    • TheraPlas
    • TheraSilence
  • PRODUCTS
    • ThermoDox
    • GEN-1
  • PIPELINE
    • Clinical Studies
    • Pre-clinical Programs
  • DISEASES
  • PUBLICATIONS
  • ABOUT US
    • Leadership
    • Board of Directors
    • Corporate Governance
Select Page

Press Releases

    Investor Relations

    • News & Investors
    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact

Press Releases

Company News

Date Title and Summary Additional Formats
Toggle Summary May 21, 2004 Celsion to Hold Annual Meeting: Shareholders may Participate By Telephone Or Webcast
Celsion to Hold Annual Meeting: Shareholders may Participate By Telephone Or Webcast Celsion to Hold Annual Meeting: Shareholders may Participate By Telephone Or Webcast Columbia, MD - May 21, 2004: CELSION CORPORATION (AMEX: CLN) will hold its annual meeting on Tuesday, May 25, 2004 at 10:15 a.m.
View HTML
Celsion to Hold Annual Meeting: Shareholders may Participate By Telephone Or Webcast 11.2 KB
Toggle Summary May 25, 2004 Celsion Clarifies FDA Warning Letter
Celsion Clarifies FDA Warning Letter COLUMBIA, MD - May 25, 2004: CELSION CORPORATION (AMEX: CLN) announced today that it has received a warning letter from the Food and Drug Administration (the FDA) regarding the Phase I and Phase II clinical trials of its Prolieveā„¢ Thermodilatation system for the
View HTML
Celsion Clarifies FDA Warning Letter 12.6 KB
Toggle Summary May 28, 2004 Celsion Demands Immediate End To Unauthorized Trading On Berlin-Bremen Stock Exchange
Celsion Demands Immediate End To Unauthorized Trading On Berlin-Bremen Stock Exchange Columbia, MD - May 28, 2004: CELSION CORPORATION (AMEX: CLN) announced today that it has learned that its common stock has been listed on the Berlin-Bremen Stock Exchange without the Company's prior knowledge,
View HTML
Celsion Demands Immediate End To Unauthorized Trading On Berlin-Bremen Stock Exchange 10.9 KB
Toggle Summary Jun 1, 2004 Celsion Submits Response to FDA Warning Letter
Celsion Submits Response to FDA Warning Letter Columbia, MD - June 1, 2004: CELSION CORPORATION (AMEX: CLN) announced today that its response to the warning letter issued to it by the Food and Drug Administration (FDA) on May 7, 2004 was submitted to the FDA on Friday, May 28, 2004.
View HTML
Celsion Submits Response to FDA Warning Letter 11.7 KB
Toggle Summary Aug 31, 2004 FDA Clears Celsion to Initiate Clinical Trials for the Use of ThermoDox with RFA in the Treatment of Liver Cancer
FDA Clears Celsion to Initiate Clinical Trials for the Use of ThermoDox with RFA in the Treatment of Liver Cancer COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 31, 2004--CELSION CORPORATION (AMEX:CLN) today announced that the Food and Drug Administration (FDA) will allow the human clinical trial for its
View HTML
FDA Clears Celsion to Initiate Clinical Trials for the Use of ThermoDox with RFA in the Treatment of Liver Cancer 15.9 KB
Toggle Summary Sep 8, 2004 Celsion Expands Board, Appoints New Independent Director
Celsion Expands Board, Appoints New Independent Director COLUMBIA, Md.--(BUSINESS WIRE)--Sept. 8, 2004--CELSION CORPORATION (AMEX:CLN) today announced that, upon the recommendation of its Nominating Committee, effective September 7, 2004, its Board of Directors has acted to increase from five to
View HTML
Celsion Expands Board, Appoints New Independent Director 15 KB
Toggle Summary Sep 13, 2004 Celsion Announces Resignation of Vice President and Medical Director
Celsion Announces Resignation of Vice President and Medical Director COLUMBIA, Md.--(BUSINESS WIRE)--Sept. 13, 2004--CELSION CORPORATION (AMEX:CLN) today announced the resignation of Dr. William E. Gannon, as the Company's Vice President--Clinical Affairs and Medical Director. Dr.
View HTML
Celsion Announces Resignation of Vice President and Medical Director 12.7 KB
Toggle Summary Sep 13, 2004 Celsion Sets Date for 2005 Annual Meeting
Celsion Sets Date for 2005 Annual Meeting COLUMBIA, Md.--(BUSINESS WIRE)--Sept. 13, 2004--CELSION CORPORATION (AMEX:CLN) today announced that its 2005 Annual Meeting of Stockholders will be held on Thursday, May 19, 2005 at 10 o'clock a.m. Eastern Time in Columbia, Maryland.
View HTML
Celsion Sets Date for 2005 Annual Meeting 12.5 KB
Toggle Summary Sep 13, 2004 Celsion to Present at RedChip Resources Discovery Day Conference 2004
Celsion to Present at RedChip Resources Discovery Day Conference 2004 COLUMBIA, Md., Sep 13, 2004 (BUSINESS WIRE) -- CELSION CORPORATION (AMEX:CLN) announced the following webcast: What: CLN Presentation at RedChip Resources Discovery Day Conference St.
View HTML
Celsion to Present at RedChip Resources Discovery Day Conference 2004 12.8 KB
Toggle Summary Oct 21, 2004 Celsion to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference
Celsion to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference COLUMBIA, Md.--(BUSINESS WIRE)--Oct. 21, 2004--CELSION CORPORATION (AMEX:CLN) announced that its Executive Vice President and Chief Operating Officer, Tony Deasey, is scheduled to appear as a featured presenter at the
View HTML
Celsion to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference 13 KB

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • …
  • Next page Next
  • Last page Last

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • Downloads
    • RSS
    • Print
    • Search

    • Facebook
    • LinkedIn
    • Twitter
    • RSS

Celsion
Home

Technology

Products

Pipeline

Disease

Publications

News & Investors

About Us

Careers

Privacy Policy

LinkedIn

    ThermoDox is a registered trademark of Celsion Corporation.
    TheraPlas and TheraSilence are trademarks of Celsion Corporation.
    Avastin is a registered trademark of Genentech, Inc.
    Copyright © 2022 Celsion Corporation. All rights reserved.

    • Twitter
    • Facebook
    • LinkedIn
    Share This
    • Twitter
    • Google+
    • Facebook
    • LinkedIn